Discuss This Disease

4 free views remaining today

sea-blue histiocytosis

Description

Sea-blue histiocytosis: A rare condition characterized by abnormal histiocytes

Sea-blue histiocytosis is a rare and benign condition that affects the body's histiocytes, a type of macrophage. The condition is characterized by the presence of large macrophages with blue-green granules in their cytoplasm, which can be seen under a microscope.

Key features:

  • Abnormal histiocytes: Sea-blue histiocytosis is marked by the presence of abnormal histiocytes that have an increased lipid content, giving them a sea-blue appearance.
  • Splenomegaly: The condition often leads to splenomegaly (enlargement of the spleen).
  • Mild thrombocytopenia: Mild thrombocytopenia (low platelet count) is also commonly associated with sea-blue histiocytosis.
  • Progressive neurological disease: In some cases, the condition can lead to progressive neurological disease, including symptoms such as ataxia and weakness.

Causes:

Sea-blue histiocytosis can occur as a familial inherited syndrome or as an acquired secondary or systemic infiltrative process. It is often associated with other conditions, such as Niemann-Pick disease type B.

Diagnosis:

The condition is typically diagnosed through microscopic examination of bone marrow or spleen tissue, which shows the presence of abnormal histiocytes.

References:

  • [1] Sea-blue histiocytosis is a rare condition that can be often identified in bone marrow, spleen, liver as well as other organs. (Source: Search result 7)
  • [2] The condition is characterized by splenomegaly, mild thrombocytopenia, and progressive neurological disease (eg, ataxia, weakness). (Source: Search result 8)
  • [3] Sea-blue histiocytosis is a benign condition that affects the body's histiocytes. (Source: Search result 1)

Additional Characteristics

  • Splenomegaly
  • Abnormal histiocytes with an increased lipid content
  • Mild thrombocytopenia
  • Progressive neurological disease
  • Familial inherited syndrome or acquired secondary process

Signs and Symptoms

Common Signs and Symptoms of Sea-Blue Histiocytosis

Sea-Blue Histiocytosis, also known as inherited lipemic splenomegaly, is an extremely rare condition characterized by elevated triglyceride levels (hypertriglyceridemia) and an enlarged spleen (splenomegaly). The following are some possible signs and symptoms of this condition:

  • Enlarged Spleen (Splenomegaly): This is a common feature of Sea-Blue Histiocytosis, where the spleen becomes significantly larger than normal.
  • Elevated Triglyceride Levels: High levels of triglycerides in the blood are a hallmark of this condition.
  • Low Platelet Count (Thrombocytopenia): A decrease in platelet count can be observed in some cases.
  • Liver Function Abnormalities: Liver function tests may show abnormalities, indicating potential liver damage.
  • Heart Disease: Heart disease is also associated with Sea-Blue Histiocytosis.

Additional Signs and Symptoms

In addition to the above symptoms, other signs and symptoms of Sea-Blue Histiocytosis may include:

  • Severe abdominal pain
  • Ataxia (loss of coordination)
  • Progressive neurological disease

Rare but Possible Symptoms

Some rare but possible symptoms of Sea-Blue Histiocytosis include:

  • Bone marrow involvement
  • Mild thrombocytopenia
  • Splenomegaly in the presence of numerous histiocytes stained a sea-blue color.

These symptoms are based on information from various medical sources, including [10], [11], and [13].

Diagnostic Tests

Treatment

Treatment Options for Sea-Blue Histiocytosis

Sea-blue histiocytosis, a rare condition characterized by elevated triglyceride levels and an enlarged spleen, typically requires management of symptoms and prevention of complications. While there is no specific treatment to cure the disorder or remove sea blue histiocytes from the body, various medications can be used to alleviate symptoms.

  • Triglyceride-lowering drugs: Fibrates, such as fenofibrate, can be prescribed to promptly lower plasma triglyceride levels [8].
  • Medications for symptom management: Treatment options may vary depending on the severity of the disease and the patient's general health. Medications may include those used to manage symptoms like splenomegaly, hypertriglyceridemia, or other related conditions.
  • Supportive care: In addition to medications, supportive care such as transfusions (e.g., platelets) may be necessary in certain cases [6].

It's essential to note that treatment options for sea-blue histiocytosis are often tailored to the individual patient and may

Recommended Medications

  • Supportive care
  • Medications for symptom management
  • Fibrates

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Sea-Blue Histiocytosis

Sea-blue histiocytosis (SBH) is a rare condition characterized by the presence of sea-blue histiocytes in the bone marrow. The differential diagnosis of SBH involves identifying conditions that may mimic its presentation.

  • Macrophages containing hemosiderin: One of the key differential diagnoses for SBH is macrophages containing hemosiderin, which can also appear as blue-colored cells in the bone marrow (4).
  • Tangier disease and chylomicronaemia: In patients with hyperlipidaemia, the main differential diagnosis for SBH are Tangier disease and chylomicronaemia, both of which involve abnormalities in lipid metabolism (6).

Associated Conditions

SBH is associated with various conditions, including:

  • Haematological disorders: Chronic myeloid leukaemia (CML), polycythaemia vera (PV), and myelodysplastic syndromes have been reported to be associated with SBH (5).
  • Lipid metabolic disorders: SBH accompanies a variety of conditions, including genetic and acquired lipid metabolic or ceroid storage disorders (7).

Other Considerations

SBH is generally seen in conditions where the turnover of cells is high, such as certain haematological malignancies like CML (9). It's essential to consider these factors when differentiating SBH from other conditions.

References: [4] [8]

Additional Differential Diagnoses

  • Myelodysplastic syndromes
  • Macrophages containing hemosiderin
  • Chronic myeloid leukaemia (CML)
  • Polycythaemia vera (PV)
  • Tangier disease

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10893
owl#annotatedSource
t432482
oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
OMIM mapping confirmed by DO. [SN].
oboInOwl#id
DOID:4423
core#notation
DOID:4423
oboInOwl#hasDbXref
UMLS_CUI:C0036489
IAO_0000115
A sphingolipidosis characterized by dysfunctional metabolism of sphingolipids.
oboInOwl#hasExactSynonym
Sea-blue histiocyte syndrome
rdf-schema#label
sea-blue histiocytosis
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_1927
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.